188 related articles for article (PubMed ID: 32801146)
1. Reelin depletion protects against autoimmune encephalomyelitis by decreasing vascular adhesion of leukocytes.
Calvier L; Demuth G; Manouchehri N; Wong C; Sacharidou A; Mineo C; Shaul PW; Monson NL; Kounnas MZ; Stüve O; Herz J
Sci Transl Med; 2020 Aug; 12(556):. PubMed ID: 32801146
[TBL] [Abstract][Full Text] [Related]
2. Safety of Anti-Reelin Therapeutic Approaches for Chronic Inflammatory Diseases.
Calvier L; Alexander A; Marckx AT; Kounnas MZ; Durakoglugil M; Herz J
Cells; 2024 Mar; 13(7):. PubMed ID: 38607022
[TBL] [Abstract][Full Text] [Related]
3. Lack of junctional adhesion molecule (JAM)-B ameliorates experimental autoimmune encephalomyelitis.
Tietz S; Périnat T; Greene G; Enzmann G; Deutsch U; Adams R; Imhof B; Aurrand-Lions M; Engelhardt B
Brain Behav Immun; 2018 Oct; 73():3-20. PubMed ID: 29920328
[TBL] [Abstract][Full Text] [Related]
4. Actin-Binding Protein Cortactin Promotes Pathogenesis of Experimental Autoimmune Encephalomyelitis by Supporting Leukocyte Infiltration into the Central Nervous System.
Samus M; Li YT; Sorokin L; Rottner K; Vestweber D
J Neurosci; 2020 Feb; 40(7):1389-1404. PubMed ID: 31911458
[TBL] [Abstract][Full Text] [Related]
5. Appearance of claudin-5
Paul D; Baena V; Ge S; Jiang X; Jellison ER; Kiprono T; Agalliu D; Pachter JS
J Neuroinflammation; 2016 Nov; 13(1):292. PubMed ID: 27852330
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E receptor 2 deficiency decreases endothelial adhesion of monocytes and protects against autoimmune encephalomyelitis.
Calvier L; Manouchehri N; Sacharidou A; Mineo C; Shaul PW; Hui DY; Kounnas MZ; Stüve O; Herz J
Sci Immunol; 2021 Aug; 6(62):. PubMed ID: 34452924
[TBL] [Abstract][Full Text] [Related]
7. STEAP4 expression in CNS resident cells promotes Th17 cell-induced autoimmune encephalomyelitis.
Zhao J; Liao Y; Miller-Little W; Xiao J; Liu C; Li X; Li X; Kang Z
J Neuroinflammation; 2021 Apr; 18(1):98. PubMed ID: 33879167
[TBL] [Abstract][Full Text] [Related]
8. Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking.
Göbel K; Pankratz S; Schneider-Hohendorf T; Bittner S; Schuhmann MK; Langer HF; Stoll G; Wiendl H; Kleinschnitz C; Meuth SG
J Autoimmun; 2011 Mar; 36(2):106-14. PubMed ID: 21216565
[TBL] [Abstract][Full Text] [Related]
9. Rescue from acute neuroinflammation by pharmacological chemokine-mediated deviation of leukocytes.
Berghmans N; Heremans H; Li S; Martens E; Matthys P; Sorokin L; Van Damme J; Opdenakker G
J Neuroinflammation; 2012 Oct; 9():243. PubMed ID: 23095573
[TBL] [Abstract][Full Text] [Related]
10. Platelets contribute to the pathogenesis of experimental autoimmune encephalomyelitis.
Langer HF; Choi EY; Zhou H; Schleicher R; Chung KJ; Tang Z; Göbel K; Bdeir K; Chatzigeorgiou A; Wong C; Bhatia S; Kruhlak MJ; Rose JW; Burns JB; Hill KE; Qu H; Zhang Y; Lehrmann E; Becker KG; Wang Y; Simon DI; Nieswandt B; Lambris JD; Li X; Meuth SG; Kubes P; Chavakis T
Circ Res; 2012 Apr; 110(9):1202-10. PubMed ID: 22456181
[TBL] [Abstract][Full Text] [Related]
11. Tissue Transglutaminase contributes to experimental multiple sclerosis pathogenesis and clinical outcome by promoting macrophage migration.
van Strien ME; de Vries HE; Chrobok NL; Bol JGJM; Breve JJP; van der Pol SMP; Kooij G; van Buul JD; Karpuj M; Steinman L; Wilhelmus MM; Sestito C; Drukarch B; Van Dam AM
Brain Behav Immun; 2015 Nov; 50():141-154. PubMed ID: 26133787
[TBL] [Abstract][Full Text] [Related]
12. TRPM2 Exacerbates Central Nervous System Inflammation in Experimental Autoimmune Encephalomyelitis by Increasing Production of CXCL2 Chemokines.
Tsutsui M; Hirase R; Miyamura S; Nagayasu K; Nakagawa T; Mori Y; Shirakawa H; Kaneko S
J Neurosci; 2018 Sep; 38(39):8484-8495. PubMed ID: 30201769
[TBL] [Abstract][Full Text] [Related]
13. Artesunate Ameliorates Experimental Autoimmune Encephalomyelitis by Inhibiting Leukocyte Migration to the Central Nervous System.
Thomé R; de Carvalho AC; Alves da Costa T; Ishikawa LL; Fraga-Silva TF; Sartori A; de Oliveira AL; Verinaud L
CNS Neurosci Ther; 2016 Aug; 22(8):707-14. PubMed ID: 27165523
[TBL] [Abstract][Full Text] [Related]
14. Physical Exercise Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Peripheral Immune Response and Blood-Brain Barrier Disruption.
Souza PS; Gonçalves ED; Pedroso GS; Farias HR; Junqueira SC; Marcon R; Tuon T; Cola M; Silveira PCL; Santos AR; Calixto JB; Souza CT; de Pinho RA; Dutra RC
Mol Neurobiol; 2017 Aug; 54(6):4723-4737. PubMed ID: 27447807
[TBL] [Abstract][Full Text] [Related]
15. Caveolin-1 Is Critical for Lymphocyte Trafficking into Central Nervous System during Experimental Autoimmune Encephalomyelitis.
Wu H; Deng R; Chen X; Wong WC; Chen H; Gao L; Nie Y; Wu W; Shen J
J Neurosci; 2016 May; 36(19):5193-9. PubMed ID: 27170118
[TBL] [Abstract][Full Text] [Related]
16. Absence of system x
Merckx E; Albertini G; Paterka M; Jensen C; Albrecht P; Dietrich M; Van Liefferinge J; Bentea E; Verbruggen L; Demuyser T; Deneyer L; Lewerenz J; van Loo G; De Keyser J; Sato H; Maher P; Methner A; Massie A
J Neuroinflammation; 2017 Jan; 14(1):9. PubMed ID: 28086920
[TBL] [Abstract][Full Text] [Related]
17. Naringenin attenuates experimental autoimmune encephalomyelitis by protecting the intact of blood-brain barrier and controlling inflammatory cell migration.
Niu X; Sang H; Wang J
J Nutr Biochem; 2021 Mar; 89():108560. PubMed ID: 33249188
[TBL] [Abstract][Full Text] [Related]
18. Translocator Protein Ligand PIGA1138 Reduces Disease Symptoms and Severity in Experimental Autoimmune Encephalomyelitis Model of Primary Progressive Multiple Sclerosis.
Tremolanti C; Cavallini C; Meyer L; Klein C; Da Pozzo E; Costa B; Germelli L; Taliani S; Patte-Mensah C; Mensah-Nyagan AG
Mol Neurobiol; 2022 Mar; 59(3):1744-1765. PubMed ID: 35018577
[TBL] [Abstract][Full Text] [Related]
19. Ulinastatin attenuates experimental autoimmune encephalomyelitis by enhancing anti-inflammatory responses.
Feng M; Shu Y; Yang Y; Zheng X; Li R; Wang Y; Dai Y; Qiu W; Lu Z; Hu X
Neurochem Int; 2014 Jan; 64():64-72. PubMed ID: 24274996
[TBL] [Abstract][Full Text] [Related]
20. Chimeric CNS-targeting-peptide engineered exosomes for experimental autoimmune encephalomyelitis therapy.
Wang YK; Zhao YP; Ye MZ; Wang L; Lan TS; Wang Y; Qi ZQ
Int Immunopharmacol; 2023 Nov; 124(Pt B):110835. PubMed ID: 37717320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
